A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
Phase of Trial: Phase III
Latest Information Update: 15 May 2019
Price : $35 *
At a glance
- Drugs IDP 124 (Primary)
- Indications Atopic dermatitis
- Focus Registrational; Therapeutic Use
- Sponsors Bausch Health Companies; Ortho Dermatologics
- 24 Apr 2019 Planned End Date changed from 1 Mar 2019 to 1 Nov 2019.
- 24 Apr 2019 Planned primary completion date changed from 1 Feb 2019 to 1 Sep 2019.
- 24 Apr 2019 Status changed from not yet recruiting to recruiting.